At a dosage of 150 mg/kg, SIN hindered osteosarcoma metastasis by inhibiting RANKL-mediated osteolysis, regulating intracellular alkaline phosphatase (ALP) expression, improving cortical bone integrity, and reducing osteoclast numbers [26]. Here, TNFSF11 is linked to osteosarcoma.